CHEK trade ideas
Chek Harmonics: Fishing for Round ThreeHere, we have what appears to be a clear 3-drive pattern. I noticed that each spike is on a Monday, within one plus or minus approximately 1 week of a quadruple witching day. Furthermore, time ratios indicated the pop COULD happen anytime between the purple vertical lines; however, the pattern is likely to complete within the trendline area as well. Therefore, the trading idea here is to buy as low as possible every Friday for the swing into Monday, since you are buying low and price seems to be technically in an uptrend and pretty forgiving currently. One could easily get out without a loss. No harm, no foul. Good luck and trade safely!
$CHEK PT 5 and way higherCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.
Third Technical Analysis - CHEK Based on the historical data that the chart presents, the bottom of the trend is estimated to be at $1.92; however, there is both technical and psychological support at $ 2. This indicates there could be a slight dip under $2 temporarily in the upcoming days ( however, this seems unlikely ). Following these projections, a short-term accumulation phase will be to a price range of 2.50 to 2.75. There is strong resistance at $3; if the trend breakouts above this price, it will indicate a bullish movement to the upside to test further resistance levels and, based on the upward trend, could test $4.50. Based on the chart, I am short-term Bearish and long-term Bullish ( Since the chart overall seems to be in a uptrend ). However, if momentum is reintroduced back into this ticker, then these projections will likely happen in a shorter period.
Disclaimer: This is not financial advice. This information is provided for education and informational purposes only.
$CHEK Receives FDA IDE Approval for Pivotal Study of C-Scan®Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®
today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational Device Exemption (IDE) application, permitting Check-Cap to begin a pivotal study of C-Scan in the U.S.
The pivotal study will evaluate safety and performance of C-Scan as well as subject compliance with C-Scan.
Now with IDE in hand, we aim to enter the last phase of demonstrating the clinical potential of C-Scan in the U.S., with the ultimate goal of commercialization in this important market.
"We are in active discussions with a number of clinical sites as part of our preparations to begin the pivotal study in late 2021.
finance.yahoo.com
CHEK Check-Cap upside potential - huge volume!Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening.
Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69.
Looking at the volume, this asset can double its price is seconds.
on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target is $2.00.
Not trading advice.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.